Abstract
Despite significant advances in stem cell manipulation and post-transplant immunosuppression, chronic graft-versus-host disease (cGVHD) remains a cause of major long-term morbidity in survivors of allogeneic stem cell transplantation. Extracorporeal photopheresis (ECP) is a novel therapeutic intervention which has demonstrated efficacy in patients with refractory acute and chronic GVHD. Clinical responses have been reported in skin and visceral GVHD. While the long-term immunomodulatory effects of ECP in cGVHD are unknown, recent studies of patients undergoing a 6- to 12-month course of ECP treatment demonstrated an attenuation of Th1-mediated cytokine secretion by activated T-helper cells, a shift in the DC1/DC2 ratio favoring plasmacytoid rather than monocytoid dendritic cell profiles, and a decrease in antigen responsiveness by dendritic cells. The implications of these immunomodulatory effects of ECP on pathogenesis and clinical outcome remains a fertile area for future research.
Original language | English (US) |
---|---|
Pages (from-to) | 719-725 |
Number of pages | 7 |
Journal | Bone marrow transplantation |
Volume | 29 |
Issue number | 9 |
DOIs | |
State | Published - 2002 |
Externally published | Yes |
Keywords
- Allogeneic BMT
- Dendritic cells
- Extracorporeal photopheresis
- Graft-versus-host disease
- T cell subsets
ASJC Scopus subject areas
- Hematology
- Transplantation